Dravet Syndrome Serum
Dravet Syndrome Serum samples are derived from donors with confirmed Dravet syndrome. Useful for assessing antiepileptic drug levels, inflammatory mediators, and systemic responses associated with epilepsy and neurodevelopmental delay.
Dravet Syndrome Human Serum for Research
Our Dravet Syndrome Serum is sourced from IRB-consented donors clinically diagnosed with Dravet Syndrome. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for disease-specific and immunological studies focused on dravet syndrome.
Product Features
- Collected from clinically confirmed Dravet Syndrome donors
- Research Use Only (RUO)
- IRB-approved protocols with documented consent
De-identified Donor Data
- Diagnosis confirmation
- Age, sex assigned at birth, and ethnicity
- Donor-reported medical history and comorbidities
Applications
- Biomarker discovery for dravet syndrome
- Serum cytokine and protein profiling
- Therapeutic candidate screening and validation
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Dravet Syndrome serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Serum Isolation
Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Serum
Frequently Asked Questions
Ask a Question
Need a custom Serum cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.